Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR 2: Stellate ganglion block vs standard antiarrhythmic therapy for electrical storm
2024-520387-34-01Phase 3Authorised
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of amiodarone, lidocaine and bupivacaine in Electrical Storm (ES), ventricular tachycardia (VT), ventricular fibrillation (VF) and 3 more (2 arms), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Complete suppression of treated ventricular arrhythmias within 3 hours. Planned start Aug 2026; status: authorised.
02
Drugs
amiodaronelidocainebupivacaine
03
Conditions
Electrical Storm (ES)ventricular tachycardia (VT)ventricular fibrillation (VF)Structural Cardiac Abnormalitycoronary arteriosclerosis
Beyond the preview
Go deeper on 2024-520387-34-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520387-34-01.